NVIDIA
NVDA
Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
US Stock MarketDetailed Quotes
VKTX Viking Therapeutics
- 38.280
- -8.420-18.03%
Close Dec 18 16:00 ET
- 38.550
- +0.270+0.71%
Post 20:02 ET
4.27BMarket Cap-40.72P/E (TTM)
43.550High37.800Low13.11MVolume43.090Open46.700Pre Close535.42MTurnover12.51%Turnover RatioLossP/E (Static)111.44MShares99.41052wk High4.68P/B4.01BFloat Cap17.23052wk Low--Dividend TTM104.78MShs Float99.410Historical High--Div YieldTTM12.31%Amplitude0.880Historical Low40.845Avg Price1Lot Size
About Viking Therapeutics Company
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Company Profile
SymbolVKTX
Company NameViking Therapeutics
Listing DateApr 29, 2015
Issue Price8.00
Founded2012
CEODr. Brian Lian, PhD
MarketNASDAQ
Employees27
Fiscal Year Ends12-31
Address9920 Pacific Heights Boulevard,Suite 350
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-704-4660
Company Executives
-
Name
- Position
- Salary
-
Dr. Brian Lian, PhD
- President, Chief Executive Officer and Director
- 12.63M
-
Marianne Mancini
- Chief Operating Officer
- 3.51M
-
Greg S. Zante
- Chief Financial Officer and Principal Accounting Officer
- 3.50M
-
Matthew W. Foehr
- Independent Director
- 169.37K
-
J. Matthew Singleton
- Independent Director
- 192.77K
-
Charles A. Rowland, Jr,M.B.A.
- Independent Director
- 189.62K
-
Dr. S. Kathryn Rouan, PhD
- Independent Director
- 178.65K
-
Dr. Lawson Macartney, D.V.M.,PhD
- Chairperson of the Board
- 222.72K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
